Delivery Order SPE2DR25D2013-SPE2DR26F5QZZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,363.86 to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe format on January 8, 2026, with an ultimate completion date of January 9, 2026. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a subsidiary of parent...
- The Defense Logistics Agency awarded a delivery order valued at $5,707.70 to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe format. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $11,068.93 delivery order to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe form, with an ultimate completion date of September 17, 2025. This contract represents a firm fixed-price delivery order under a competitive procurement with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters and primary distribution hub. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $137,329.89 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe form. The contract, awarded on January 14, 2026, with an ultimate completion date of January 15, 2026, operates under a firm fixed-price structure with no set-aside designation, indicating open and competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,822.80 for TWINRIX vaccine syringes (1mL, 10-count units) under a firm fixed-price contract. The award, issued on August 1, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive, non-set-aside procurement. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $7,684.86 delivery order to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe format, with an ultimate completion date of January 20, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $26,832.78 to AmerisourceBergen Drug Corp for the supply of TWINRIX syringes (1mL, 10-count units) with a firm fixed price structure. This competitive award, announced on December 16, 2025, with an ultimate completion date of January 14, 2026, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a potential value of...
- The Defense Logistics Agency awarded a delivery order valued at $1,761.15 to AmerisourceBergen Drug Corp for the supply of TWINRIX vaccine in syringe format on January 7, 2026, with an ultimate completion date of January 8, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,215.76 to AmerisourceBergen Drug Corp for TWINRIX vaccine syringes, with an ultimate completion date of October 31, 2025. This is a firm fixed price, non-set-aside contract for delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5QZZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,141.97 to AmerisourceBergen Drug Corp for the supply of TWINRIX vaccine in syringe format. The contract, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, represents a firm fixed-price purchase under a competitive, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive $1 billion global pharmaceutical support vehicle valued through December 2026 that enables AmerisourceBergen to supply a broad range of pharmaceutical products, vaccines, and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical federal medical procurement vendor. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill government pharmaceutical supply requirements across multiple therapeutic domains through competitively awarded delivery orders. The DLA Troop Support Medical IDC serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the company positioned to continue supporting these agencies as the DLA pursues its Pharmaceutical Prime Vendor Global Program Generation V contracts through multiple regional awards anticipated in the coming years.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 1/19/26 |